ArticleIn silico pharmacology2021

In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus.

Borris Rosnay Tietcheu Galani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.